# Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing

> **NCT02368639** · NA · TERMINATED · sponsor: **Fisher and Paykel Healthcare** · enrollment: 14 (actual)

## Conditions studied

- Sleep Apnea, Obstructive
- Obesity Hypoventilation Syndrome

## Interventions

- **DEVICE:** Fisher & Paykel Healthcare PAP Device

## Key facts

- **NCT ID:** NCT02368639
- **Lead sponsor:** Fisher and Paykel Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study was terminated due to recruitment slower than anticipated
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02368639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02368639, "Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT02368639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
